Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Radiotherapy & Radiosurgery
Radiosurgery of a brain tumor
What stereotactic radiosurgery of a brain tumor is, how focused radiation beams target intracranial lesions without craniotomy, and what evidence shows for metastases, meningiomas, and schwannomas. This guide explains approximate costs in Turkey compared with the UK, US, and Germany, the step-by-step treatment day, realistic scan outcomes, recovery milestones, side effects, and how to evaluate accredited neuro-oncology centres.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Radiotherapy & Radiosurgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Radiosurgery of a Brain Tumor
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Radiosurgery of a brain tumor: what it is and how stereotactic radiation works
Radiosurgery of a brain tumor (stereotactic radiosurgery or SRS) is a non-invasive radiation technique that delivers focused, high-dose beams of ionising radiation to an intracranial target in a single session or a few fractionated visits. Despite the term radiosurgery, there is no scalpel, incision, or opening of the skull. Advanced computerised mapping directs hundreds of narrow radiation beams from multiple angles so they converge precisely on the lesion. While each individual beam passes harmlessly through normal brain tissue, the point of intersection receives a concentrated dose that halts abnormal cell division and damages tumour DNA.
Hospitals providing radiosurgery of a brain tumor in Turkey use stereotactic systems for benign and malignant brain tumours, vascular malformations, and functional conditions. Because the technique protects adjacent healthy brain tissue, it is a proven alternative to open craniotomy for deep-seated tumours or patients who cannot undergo general anaesthesia. For wider treatment pathways, see our guide to oncology treatments in Turkey.
Does radiosurgery of a brain tumor actually work?
Clinical studies and guidelines from professional bodies, including the National Institute for Health and Care Excellence (NICE) and the American Society for Radiation Oncology (ASTRO), confirm that stereotactic radiosurgery achieves local tumour control rates exceeding 85% to 90% for small brain metastases, meningiomas, and acoustic neuromas (vestibular schwannomas). Treatment halts cell division, causing the tumour to shrink gradually or remain permanently stable.
However, radiosurgery does not remove the lesion instantly, and radiographic changes take months or years to appear on magnetic resonance imaging (MRI). Furthermore, it is not a curative treatment for diffuse, infiltrative primary tumours such as glioblastoma multiforme, where microscopic cancer cells extend far beyond visible borders. Trustworthy neuro-oncology teams discuss these limitations openly and never promise immediate eradication.
Radiosurgery of a brain tumor cost in Turkey compared with the UK, US and Germany
The radiosurgery of a brain tumor price and overall treatment cost depend on the technology used (such as Gamma Knife or robotic linear accelerators), the number of treatment sessions, planning complexity, and whether hospital observation is required. The table below outlines approximate price ranges across major medical travel destinations. These figures are broad estimates rather than individual hospital quotes.
| Country | Approximate cost range |
|---|---|
| Turkey | €3,000 – €7,500 |
| United Kingdom | €8,000 – €18,000 |
| United States | €14,000 – €38,000 |
| Germany | €7,500 – €16,000 |
In Turkey, radiosurgery of a brain tumor cost is lower primarily due to lower operational expenses and competitive national tariffs rather than differences in medical standards. Accredited Turkish hospitals utilise modern linear accelerator and cobalt-60 systems comparable to European centres. A standard international package includes simulation MRI and CT scans, dosimetry calculations, specialist fees, radiation delivery, and airport transfers. Always obtain a written breakdown before travelling.
Stereotactic radiosurgery vs open craniotomy and whole-brain radiation
Neuro-oncology teams evaluate radiosurgery against open surgical resection and conventional whole-brain radiotherapy (WBRT) based on tumour size, location, and the patient's general health.
| Treatment approach | Best suited to | Typical limits |
|---|---|---|
| Stereotactic radiosurgery (SRS) | Small, well-defined tumours (under 3–4 cm) and deep skull-base lesions | Does not relieve immediate pressure from large tumours |
| Open craniotomy (resection) | Large tumours with significant mass effect or needing tissue biopsy | Invasive surgery requiring general anaesthesia and hospitalisation |
| Whole-brain radiotherapy (WBRT) | Multiple widespread brain metastases throughout both hemispheres | Higher risk of neurocognitive decline, fatigue, and hair loss |
Specialised systems include Gamma Knife, which uses focused cobalt-60 beams through a stereotactic head frame, and robotic or linear accelerators with image guidance. For complex or extensive anatomical areas, platforms such as tomotherapy provide rotational radiation delivery tailored to sensitive tissues.
Which types of brain tumors can radiosurgery treat?
Stereotactic radiosurgery is suitable for well-defined intracranial lesions visible on contrast-enhanced neuroimaging. Common indications include:
- Brain metastases: Secondary tumours spreading from primary lung, breast, renal, or melanoma cancers. Radiosurgery treats single or multiple lesions while sparing healthy brain tissue.
- Vestibular schwannomas (acoustic neuromas): Benign tumours on the balance and hearing nerve, where radiation controls growth and helps preserve facial nerve function.
- Meningiomas: Non-cancerous tumours arising from the protective brain membranes, particularly at skull-base locations where surgical access is challenging.
- Pituitary adenomas: Benign growths of the pituitary gland that persist or recur after surgery or medication.
- Arteriovenous malformations (AVMs): Vascular tangles in the brain that gradually close off following stereotactic irradiation.
Who is a candidate for brain tumor radiosurgery, and who is not?
Good candidates are patients with discrete tumours under 3 to 4 centimetres in diameter, clear radiographic margins, and stable overall health. Radiosurgery is especially valuable for lesions in surgically inaccessible brain regions, recurrent metastases, or individuals unable to undergo general anaesthesia due to cardiac or pulmonary conditions.
You are less suited for radiosurgery if your tumour causes severe mass effect, midline shift, or acute intracranial pressure requiring immediate physical decompression. Diffuse, infiltrative malignancies with indistinct borders cannot receive curative ablative doses safely. Patients with extensive leptomeningeal disease or severe claustrophobia that prevents immobility during treatment also require alternative approaches.
The treatment procedure step by step: mapping, planning and delivery
Brain tumour radiosurgery is typically completed as a single-day outpatient visit structured in four sequential stages:
1. Immobilisation
A stereotactic head frame secured with local anaesthetic pins, or a custom-fitted thermoplastic mask for frameless systems, holds your head completely still.
2. Simulation imaging
High-resolution contrast MRI and volumetric CT scans map the exact three-dimensional coordinates of the tumour and neighbouring critical structures, including the optic nerves and brainstem.
3. Dosimetric planning
While you relax, a medical physicist and radiation oncologist use computer software to model hundreds of beam paths, concentrating the radiation dose on the tumour while protecting healthy brain tissue.
4. Radiation delivery
You lie on the treatment couch as the machine rotates quietly to deliver the planned radiation. The session lasts 30 to 90 minutes. Radiation beams cannot be felt, and you can speak with the clinical team via intercom throughout.
Radiosurgery before and after: what imaging shows and realistic outcomes
Unlike open surgery where a tumour is physically excised, radiosurgery works biologically over time. Evaluating outcomes requires follow-up scans rather than immediate visual changes.
On follow-up MRI scans performed at 3, 6, and 12 months, successful radiosurgery appears as tumour stability (cessation of growth) or gradual shrinkage. For benign tumours such as meningiomas and schwannomas, long-term stabilization without expansion is considered a successful outcome. Brain metastases often show central necrosis before reducing in volume.
In the first 6 to 18 months, treated tissue can temporarily swell or enhance more brightly on contrast MRI. This phenomenon, known as pseudoprogression or radiation necrosis, can mimic tumour recurrence. Experienced neuro-radiologists evaluate serial scans alongside clinical symptoms before deciding whether medication or intervention is necessary.
Your trip to Turkey and radiosurgery of a brain tumor recovery
When travelling for radiosurgery of a brain tumor Turkey visits usually span 4 to 6 days. A typical schedule includes:
- Day 1: Arrival, hospital registration, initial consultation with your neurosurgeon and radiation oncologist, and baseline assessments.
- Day 2: Frame or mask fitting, simulation MRI and CT scans, and computerized dosimetric planning.
- Day 3: Radiosurgery delivery session followed by a short period of clinical observation. (Staged treatments occur across 2–5 days).
- Day 4–5: Follow-up examination, medication review, fit-to-fly confirmation, and journey home.
For radiosurgery of a brain tumor recovery is rapid. Mild fatigue or a slight headache may occur for 24 to 48 hours, usually managed with simple pain relief. Most people return to light desk work within 2 to 3 days and resume normal daily activities within a week. Strenuous exercise should be paused for two weeks. Long-term monitoring relies on MRI scans at 3, 6, and 12 months, which can be done locally and sent to your Turkish medical team for review.
Risks, side effects and safety considerations
Stereotactic radiosurgery is a precise procedure, but ionising radiation can cause side effects. According to clinical guidelines from the European Society for Radiotherapy and Oncology (ESTRO) and ASTRO, risks fall into acute and delayed effects:
- Acute effects (days to weeks): Mild headache, fatigue, temporary nausea, and local pin-site soreness if a frame was used. Transient brain swelling (oedema) around the tumour can temporarily exacerbate neurological symptoms and is treated with a short course of oral corticosteroids.
- Radiation necrosis (months to years): Localised breakdown of radiated tissue occurs in roughly 5% to 10% of cases, depending on tumour volume and previous radiation exposure. Many cases resolve spontaneously or respond to anti-inflammatory medication.
- Neurological deficits: Tumours close to cranial nerves or the optic apparatus carry a small risk of localized nerve dysfunction or seizure activity in predisposed patients.
How to choose a neuro-oncology centre and questions to ask
Choose a hospital with international accreditation (such as JCI) and a dedicated multidisciplinary tumour board where neurosurgeons, radiation oncologists, and medical physicists jointly evaluate your scans. Avoid clinics that quote prices without seeing your MRI, promise instant cures, or cannot identify your treating physicians.
Key questions to ask the medical team:
- Will a multidisciplinary neuro-oncology board review my MRI scans before planning?
- Which radiosurgery platform is recommended for my tumour, and why?
- What margins and dose constraints will be used to protect healthy brain tissue?
- What aftercare protocol is provided if I experience headache or swelling after returning home?
- How will my follow-up MRI scans be reviewed remotely?
Learn more about travel planning on our how our coordination works page, or submit your medical imaging through our free quote portal to receive a detailed clinical opinion and cost estimate.
Hospitals with Oncology in Turkey
Frequently asked questions
Radiosurgery of a brain tumor is a non-invasive treatment that focuses hundreds of narrow radiation beams onto an intracranial lesion without incisions or surgical opening of the skull. The converging beams deliver an intense radiation dose to the tumor while minimizing exposure to surrounding healthy brain tissue.
Yes. Clinical guidelines report local tumor control rates exceeding 85% to 90% for small brain metastases, meningiomas, and acoustic neuromas. Radiation halts cell division, stabilizing the lesion or causing it to shrink over time. It is not suitable for large tumors requiring urgent surgical decompression.
Radiosurgery of a brain tumor cost in Turkey typically ranges from €3,000 to €7,500, compared with €8,000 to €18,000 in the UK and €14,000 to €38,000 in the US. The price depends on whether single-session or fractionated delivery is needed, dosimetric planning complexity, and package inclusions.
Unlike surgery where a tumor is excised immediately, radiosurgery results appear on follow-up MRI scans over several months. Successful treatment is demonstrated by tumor shrinkage or long-term growth arrest. Temporary swelling can occur in the first year, which neuroradiologists distinguish from true tumor progression.
Recovery is rapid because there are no surgical wounds. Most patients experience mild fatigue or headache for 24 to 48 hours and return to light desk work within two to three days. Strenuous exercise is typically avoided for two weeks, and progress is monitored with periodic MRI scans.
The radiation beams themselves cannot be felt. Patients fitted with a stereotactic head frame receive local anaesthetic injections at the pin sites, which cause brief stinging followed by numbness. Frameless treatments using a moulded mesh mask are completely non-invasive, though mild headaches or fatigue can occur after delivery.
For benign tumors such as meningiomas and schwannomas, growth control achieved through radiosurgery is typically long-lasting or permanent. For brain metastases, treated lesions often remain controlled, though ongoing oncological surveillance is essential because new metastases can arise elsewhere in the brain from the underlying primary cancer.
Radiosurgery is well-tolerated and avoids the anaesthetic, bleeding, and infection risks of open skull surgery. Common temporary effects include fatigue and mild brain swelling treatable with corticosteroids. Rare complications include radiation necrosis, which affects roughly 5% to 10% of cases and is managed with close clinical monitoring.
Radiosurgery is suited to small, discrete lesions under 3 to 4 centimetres, deep skull-base tumors, and patients unable to have surgery. Open craniotomy remains necessary for large lesions causing acute brain compression. Whole-brain radiotherapy is reserved for widespread metastases where targeted radiosurgery cannot cover every lesion.
Most patients spend four to six days in Turkey. This allows time for arrival, consultation, simulation CT and MRI scans, dosimetry calculations, the treatment session, and post-procedure neurological review before flying home. Staged fractionated treatments may require an additional two to three days.
Patient stories